Boom Or Bust: What Is Next For Bone Biologics Corp (NASDAQ: BBLG) Stock?

Bone Biologics Corp (NASDAQ:BBLG)’s traded shares stood at 0.13 million during the last session. At the close of trading, the stock’s price was $3.49, to imply a decrease of -3.59% or -$0.13 in intraday trading. The BBLG share’s 52-week high remains $25.50, putting it -630.66% down since that peak but still an impressive 4.01% since price per share fell to its 52-week low of $3.35. The company has a valuation of $4.68M, with an average of 2.89 million shares in intraday trading volume over the past 10 days and average of 493.12K shares over the past 3 months.

Bone Biologics Corp (NASDAQ:BBLG) trade information

After registering a -3.59% downside in the last session, Bone Biologics Corp (BBLG) has traded red over the past five days. The 5-day price performance for the stock is -16.11%, and -27.32% over 30 days. With these gigs, the year-to-date price performance is -51.53%. Short interest in Bone Biologics Corp (NASDAQ:BBLG) saw shorts transact 29866.0 shares and set a 0.46 days time to cover.

BBLG Dividends

Bone Biologics Corp has its next earnings report out on 2025-May-12. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

Bone Biologics Corp (NASDAQ:BBLG)’s Major holders

Bone Biologics Corp insiders hold 0.12% of total outstanding shares, with institutional holders owning 1.10% of the shares at 1.10% float percentage. In total, 1.10% institutions holds shares in the company, led by UBS GROUP AG. As of 2024-06-30, the company held over 33707.0 shares (or 5.1% of shares), all amounting to roughly $41123.0.

The next major institution holding the largest number of shares is HRT FINANCIAL LP with 17519.0 shares, or about 2.6507% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $21000.0.

We also have Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Total Market Index Fund as the top two Mutual Funds with the largest holdings of the Bone Biologics Corp (BBLG) shares. Going by data provided on Apr 30, 2025, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund holds roughly 2.75 shares. This is just over 0.50% of the total shares, with a market valuation of $9607.0. Data from the same date shows that the other fund manager holds a little less at 656.0, or 0.12% of the shares, all valued at about 2289.0.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.